Metformin associated lactic acidosis;Metforminassosiert laktacidose - Pasienteksempel og litteraturgjennomgang

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 13, 2000, Pages 1539-1541

  Løvås, Kristian ^a,b   Fadnes, Dag Jone ^a,c   Dale, Astrid ^a  

^a Medisinsk Avdeling   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Garnisonen I Porsanger ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; HYPERTENSIVE AGENT; METFORMIN; ANTIDIABETIC AGENT;

AGED; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; LACTIC ACIDOSIS; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; TREATMENT CONTRAINDICATION; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; FATALITY; REVIEW;

ACIDOSIS, LACTIC; AGED; FATAL OUTCOME; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; PROGNOSIS;

EID: 0034690797     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Carlsen SM, Følling I. Metformin revurderttid for rehabilitering? Tidsskr Nor Lægeforen 1994; 114: 1074-6.
2. Carlsen SM. Bør insulinbehandling unngås? Blodsukkeret betyr ikke alt hos type: 2-diabetikere. Tidsskr Nor Lægeforen 1995; 115: 2271-5.
3. Birkeland KI, Vaaler S, Hanssen KF. Insulin-behandling er nyttig - også ved type 2-diabetes. Tidsskr Nor Lægeforen 1996; 116: 1233-5.
4. Bailey CJ, Path MRC, Turner RC. Metformin. N Engl J Med 1996; 334: 574-9.
5. United Kingdom Prospective Diabetes Study Group. UKPDS 13: relative efficiacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995; 310: 83-8.
6. United Kingdom Prospective Diabetes Study Group. UKPDS 34: effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 1998; 352: 854-65.
7. Legemiddelforbruket i Norge 1994-1998. Oslo: Norsk Medisinaldepot, 1999.
8. Bailey CJ. Metformin - an update Gen Pharmac 1993; 24: 1299-309.
9. Lalau JD, Mourlhon C, Bergeret A, Lacroix C. Consequences of metformin intoxication. Diabetes Care 1998; 21: 2036-7.
10. Arieff AI. Indications for use of bicarbonate in patients with metabolic acidosis. Br J Anaest 1991; 67: 165-77.
11. Gan SC, Barr J, Arieff A, Pearl RG. Biguanide-associated lactic cidosis. Case report and review of the literature. Arch Intern Med 1992; 152: 2333-6.
12. Spiller HA. Management of antidiabetic medications in overdose. Drug Saf 1998; 19: 411-24.
13. Acidosis and alkalosis. I: Harrison's Principles of Internal Medicine. 14. utg. New York: McGraw-Hill, 1998: 279-82.
14. Adrogué HJ, Rashad MN, Gorin AB, Yacoub J, Madias NE. Assessing acid-base status in circulatory failure. N Engl J Med 1989; 320: 1312-6.
15. Teale KFH, Devine A, Stewart H, Harper NJH. The management of metformin overdose. Case report. Anaesthesia 1998; 53: 691-701.
16. Ritter JM, Doktor HS, Benjamin N. Paradoxical effect of bicarbonate on cytoplasmatic pH. Lancet 1990; 335: 1243-6.
17. Heaney D, Majid A, Junor B. Bicarbonate haemodialysis as a treatment of metformin overdose. Nephrol Dial Transplant 1997; 12: 1046-7.
18. Stacpoole PW, Lorenz AC, Thomas RG, Harman E. Dichloroacetate in the treatment of lactic acidosis. Ann Intern Med 1988; 108: 58-63.
19. Lalau JD, Andrejak M, Moriniere P, Coevoet B, Debussche X, Westeel PF et al. Hemodialysis in the treatment of lactic acidosis in diabetes treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol 1989; 27: 285-8.
20. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH et al. Natural history and course of acquired lactic acidosis in adults. DCA-Lactic acidosis Study Group. Am J Med 1994; 97: 47-54.
21. Campbell IW. Metformin and glibenclamide: comparative risks. BMJ 1984; 289: 289.
22. Misbin RI, Green L, Stadel B, Gueriguian JL, Gubbi A, Fleming G. Lactic acidodis in patients treated with metformin. N Engl J Med 1998; 338: 265-6.
23. Sulkin TV, Bosman D, Krentz AJ. Contraindications to metformin therapy in patients with NIDDM. Diabetes Care 1997; 20: 925-8.
24. Gilbert RE, Cooper ME, Krum H. Drug administration in patients with diabetes mellitus. Safety considerations. Drug Saf 1998; 18. 441-55.
25. Chan NN, Fauvel NJ, Feher MD, Non-steroidal anti-inflammatory drugs and metformin: a cause for concern? Lancet 1998; 352: 201.
26. Wulf H, Mercker S, Maier C, Neumann G. Specific therapies of biguanide-induced lactic acidosis. Anesthesiology 1998; 89: 267-8.
27. Heupler FA jr. Guidelines for performing angiography in patients taking metformin. Members of the Laboratory Performance Standards Committe of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn 1998; 43: 121-3.
28. Westberg G. Sätt ut metformin före kontraströntgen! Läkartidningen 1995; 24: 2520.
29. McCartney MM, Gilbert FJ, Murchison LE, Pearson D, McHardy K, Murary AD. Metformin and contrast media - a dangerous combination? Clin Radiology 1999; 54: 29-33.
30. Rasuli P, French GJ, Hammond DI. New contraindication to intravascular contrast material. Radiology 1996; 209: 289-90.
31. Rasuli P, French GJ, Hammond DI. Metformin hydrocloride all right before, but not after, contrast medium administration. Radiology 1998; 209: 586-7.